Jennifer Miller Davis, MD
Obstetrics & Gynecology · West Linn, ORNPI 1508890179
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 30.8% of the total. Reporting peaked in 2023 at $668 and has fallen 61.9% since, to $254 in 2025.
Across 110 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$636
- Astellas Pharma US Inc$367
- Daiichi Sankyo Inc.$196
- Exact Sciences$129
- Therapeuticsmd, Inc.$109
- Myovant Sciences Inc.$91
- plus $539 from 14 others
What the payments were for
- Food & beverage$1,94494%
- Education$1236%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $636 |
| Astellas Pharma US Inc | 13 | $367 |
| Daiichi Sankyo Inc. | 12 | $196 |
| Exact Sciences | 7 | $129 |
| Therapeuticsmd, Inc. | 6 | $109 |
| Myovant Sciences Inc. | 5 | $91 |
| Agile Therapeutics, Inc. | 5 | $90 |
| Exeltis, USA Inc. | 4 | $81 |
| Organon | 3 | $60 |
| BD | 3 | $58 |
| Bausch Health US, LLC | 2 | $43 |
| Novo Nordisk | 2 | $31 |
| Medline Industries LP | 1 | $29 |
| Bayer | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Alydia Health | 2 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $23 |
| Biogen | 1 | $20 |
| Pfizer | 1 | $18 |
| Merck | 1 | $15 |
How this compares
$2,066 in reported general payments places this provider in the 85th percentile of 480 obstetrics & gynecology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $1,263 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in West Linn
- Audra Norris-JacobGresham$94K
- Amanda ClarkPortland$65K
- Robert HarderSalem$57K
- Brooke KyleSpringfield$55K
- Jeffrey JensenPortland$40K
- Timothy HutchingsMedford$23K
- Lisa BayerPortland$23K
- Denis DaliskySilverton$22K
- Rachael SmithBend$20K
- Julie KingMedford$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.